Article Information
- August 7, 2023.
Article Versions
- Version 1 (July 26, 2023 - 09:24).
- You are currently viewing Version 2 of this article (August 7, 2023 - 09:05).
- View Version 3, the most recent version of this article.
REVISION SUMMARY
nicola.barclay{at}ndorms.ox.ac.uk
marta.pinedamoncusi{at}ndorms.ox.ac.uk
annika.jodicke{at}ndorms.ox.ac.uk
daniel.prietoalhambra{at}ndorms.ox.ac.uk
braventos{at}idiapjgol.info
danielle.newby{at}ndorms.ox.ac.uk
antonella.delmestri{at}ndorms.ox.ac.uk
waiyi.man{at}ndorms.ox.ac.uk
xihang.chen{at}ndorms.ox.ac.uk
marti.catalasabate{at}ndorms.ox.ac.uk
The role of the funding sources has been updated to acknowledge that OPTIMA is funded through the IMI2 Joint Undertaking and is listed under grant agreement No. 101034347. IMI2 receives support from the European Union Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). IMI supports collaborative research projects and builds networks of industrial and academic experts in order to boost pharmaceutical innovation in Europe. The views communicated within are those of OPTIMA. Neither the IMI nor the European Union, EFPIA, or any Associated Partners are responsible for any use that may be made of the information contained herein.
Author Information
- Nicola L Barclay, PhD, Research Assistant in Health Data Sciences, Pharmaco- and Device Epidemiology1,
- Marta Pineda Moncusí, PhD, Post-Doctoral Research Assistant in Health Data Sciences, Pharmaco- and Device Epidemiology2,*,
- Annika M. Jödicke, PhD, Senior Research Associate in Pharmacoepidemiology, Pharmaco- and Device Epidemiology1,
- Daniel Prieto-Alhambra, PhD, Professor of Pharmaco- and Device Epidemiology; Head of Health Data Sciences1,3,
- Berta Raventós, MSc, Pre-doctoral Researcher4,
- Danielle Newby, PhD, Post-Doctoral Data Scientist, Pharmaco- and Device Epidemiology1,
- Antonella Delmestri, PhD, Lead Health Data Scientist1,
- Wai Yi Man, MSc, Database Programmerx1,
- Xihang Chen, MSc, Research Assistant in Health Data Sciences, Pharmaco- and Device Epidemiology1,
- Marti Català, PhD, Senior Data Scientist, Pharmaco- and Device Epidemiology1,
- The OPTIMA Consortium
- 1Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, UK
- 2Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, United Kingdom
- 3Department of Medical Informatics, Erasmus Medical Center University, Rotterdam, Netherlands
- 4Fundació Institut Universitari per a la recerca a l’Atenció Primària de Salut Jordi Gol i Gurina (IDIAPJGol), Barcelona, Spain
- ↵*Correspondence to: Marta Pineda Moncusi
, Centre for Statistics in Medicine, Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences (NDORMS), University of Oxford, Botnar Research Centre, Old Road, Headington, Oxford, OX3 7LD, United Kingdom, marta.pinedamoncusi{at}ndorms.ox.ac.uk
Subject Area
Reviews and Context
0
Comment
0
TRIP Peer Reviews
1
Community Reviews
0
Automated Services
0
Blogs/Media
Author Videos